BNF:

9.1

Status:

Do Not Prescribe (DNP), Red

Decision Date:

August 2013

Comments

RED:^1,2,3 NICE TA293: for treating chronic immune (idiopathic) thrombocytopenic purpura

DO NOT PRESCRIBE (DNP)⁶: NICE TA382 for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal) (Decision date - February 2016)

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again